Presentation Stent Design and Comprehensive Data Review: From Nobori to Ultimaster Biolimus-Eluting Stents Presenter: Shigeru Saito October 30, 2016 REGISTER for free or LOG IN to view this content Coronary Presentation TCT 2016 DES/BRS/DCB Up Next Presentation Quality-of-Life Measures as Valid Clinical Surrogates and Primary Endpoints in Randomized Trials: Why the Resistance? Presenter: John A. Spertus October 30, 2016 More slides + Presentation Outcomes and Role of Ablation in the Treatment Approach to Atrial Fibrillation Presenter: Vivek Y. Reddy October 30, 2016 Presentation Intermediate-Risk Studies I: Synthesis of the PARTNER 2A and the Sapien 3 Intermediate-Risk Trials Presenter: Susheel K. Kodali October 30, 2016 We Recommend
Presentation Quality-of-Life Measures as Valid Clinical Surrogates and Primary Endpoints in Randomized Trials: Why the Resistance? Presenter: John A. Spertus October 30, 2016
Presentation Outcomes and Role of Ablation in the Treatment Approach to Atrial Fibrillation Presenter: Vivek Y. Reddy October 30, 2016
Presentation Intermediate-Risk Studies I: Synthesis of the PARTNER 2A and the Sapien 3 Intermediate-Risk Trials Presenter: Susheel K. Kodali October 30, 2016